Elyxium Wealth Boosts Stake in Amgen by Over 600%

Elyxium Wealth LLC significantly increased its stake in Amgen Inc. (NASDAQ:AMGN) during the second quarter, according to a recent SEC filing.

The institutional investor purchased an additional 12,237 shares of the medical research company's stock, bringing its total holdings to 14,252 shares worth $5,161,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

This is not an isolated instance, as other institutional investors have also made changes to their positions in AMGN. High Note Wealth LLC increased its holdings in Amgen by 5.8% in the fourth quarter, while TAGStone Capital Inc. lifted its stake in the company by 0.7% over the same period.

The medical research company recently announced a quarterly dividend of $2.52 per share, which will be paid on September 11th to shareholders who held record as of August 21st.